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Diabetes and its associated complications have become a major concern locally, nationally and
internationally. One such complication is lower extremity amputation, commonly preceded by chronic
ulceration. The cause of this tissue breakdown is multi-faceted, but includes an increase in pressure,
particularly plantar pressure. As such, the choice of dressing to be applied to a plantar wound should ideally
not increase this pressure further. A commonly used and possibly more bulky dressing is the foam dressing.
This pilot study investigates the plantar pressures associated with three common foam dressings (Allevyn†,
Lyofoam† and Mepilex†) compared with a control dressing (Melolin†). Twelve healthy males and 19
females [SD] age 36.6 [10.4] were measured using the F-scan plantar pressure measurement system.
Substantial variations in individual pressure changes occurred across the foot. No significant differences were
identified, once a Bonferroni correction was applied. In healthy adults, it could be concluded that foam
dressings do not have any effect on the plantar pressures of the foot. However, the need remains for a robust
trial on a pathological population.
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D
iabetes mellitus has become of growing concern
locally, nationally and internationally particu-
larly in Western Society. Approximately 1.9
million Americans over the age of 20 were diagnosed in
2010 (1). Almost 27% of the population over the age of 65
years of age are now living with diabetes mellitus (1). The
lower limb complications associated with diabetes have
been well described in the literature. Lower limb amputa-
tion is 15 times more likely in people suffering from
diabetes (2) accounting for 50 75% of all non-traumatic
lower limb amputations (2, 3). Furthermore, it has been
shown that there is a 50% 5-year mortality rate associated
with a lower limb amputation (4). Research shows that
85% of lower limb amputations were preceded by
ulceration (5). Thus, it should follow that more appro-
priate ulcer management should lead to a reduction in
amputation.
The aetiology of tissue breakdown leading to neuro-
pathic and neuro-ischemic ulceration is multi-faceted,
often involving a combination of an insufficient blood
supply, increased pressure, structural deformity, fat pad
atrophy and other physiological tissue changes, biome-
chanical changes and trauma (5 12). Nervessupplying the
foot are responsible for motor, sensory and autonomic
control with deterioration of nerve function precipitating
changes in loading and ability to sense pressure on the
foot. A breakdown of the sensory system impairs a
person’s ability to detect forces applied to the foot. These
forces may present as a high energy force in a singular
incident (traumatic injury) or as a moderate force over a
longer period, as may occur with plantar pressures in
standing and walking (6, 7, 13). These plantar pressures
may be broken down into vertical and shear components,
bothofwhichmayplayaroleintissuebreakdown(14,15).
The method by which mild to moderate energy
(pressure) causes tissue damage is not as well understood.
There are two seemingly opposing and separate theories.
Firstly, it is suggested that moderate but long lasting
pressures on the foot can lead to localised ischemia (7, 13,
16 19). Blood is forced from the tissues leading to
necrosis (7, 13, 16, 17). For this to occur, the pressures
need to reach levels greater than the pressure filling the
tissues (17). Kosiak was instrumental in the development
of this theory with a classic experiment of exposing dogs
to closely controlled pressures for extended periods (7).
Alternatively, it is thought that inflammation may occur
in some of the tissues as a result of repetitive moderate
pressures resulting in callus formation and further
pressure increases. This was shown in a series of studies
by Brand on rat footpads many years previously (6).
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will then occur (6, 16 19). Ensuing fluid buildup will
become trapped and put further pressure on the deeper
tissues resulting in a deeper ulcerative lesion. It appears
most likely that a combination of these pathological
mechanisms contributes to plantar ulcer formation in the
neuropathic patient.
Management of neuropathic ulcers is multi-faceted,
addressing all the factors that may affect or impede
healing. This includes ensuring adequate blood supply,
management and prevention of infections and bacterial
burden, control of blood glucose levels and nutritional
status, wound debridement, careful selection of appro-
priate dressings to achieve the appropriate wound envir-
onment and a decrease in or elimination of excessive
plantar pressures (7 12, 19 32).
Due to the role played by pressure and deformity, an
appropriate dressing choice is vital. Seaman (33) stated
that an ideal wound dressing maintains a moist wound
environment, absorbs excess exudate, eliminates dead
space, does not harm the wound and provides thermal
insulation and a bacterial barrier. It would also seem
important that a dressing should not exacerbate wound
breakdown by increasing plantar pressure or decreasing
the vascular supply. The choice of dressing type may,
therefore, be an important consideration in wound
management. One group commonly chosen for use on
the plantar surface of the wound is foams. Foam
dressings are used for moderate to high exudative wounds
to manage excessive moisture levels.
As outlined by Wolfe et al. 1991 in Foley (34), the
quantity of pressure acting on a specific area of the foot is
directly dependent upon the force applied to the foot and
inversely dependent on the area to which the force is
applied. If you apply a dressing particularly of a smaller
size, it would seem reasonable that thiswill act like a focus
point, much like a prominent joint, decreasing the area
over which the force is applied. Therefore, the addition of
this material on the bottom of the foot, specifically on the
site of pathology, may have the effect of increasing plantar
pressures leading to further wound breakdown via in-
flammatory autolytic or localised ischaemic processes or
simply result in a delay of healing (Fig. 1).
Conversely, many professionals believe that the foam
dressing is able to ‘cushion’ the wound. Therefore, it is
important that the relationship between the application
of a dressing and corresponding pressure change on the
plantar surface of the foot be established.
A literature search was undertaken but only three
articles were found which might relate to the likely effects
of foam dressings on plantar pressures within the foot. Of
the three identified articles, the first, by Ashford and
colleagues (35), reported an in vitro evaluation of the
characteristics of four different foams readily available in
the marketplace. This article was an overview of dressing
material characteristics and durability that will prove
useful for describing effects observed in in vivo studies of
foam dressings during dynamic testing. Four foam
dressings (Allevyn†, Biatain†, Lyofoam† and Tielle†)
were put through a series of tests (35). This included a dry
compression test, wet compression test, shear test and
cyclical test procedure. The results varied across the
gamut of tests, with different dressings performing
differently under different conditions. The authors con-
cluded that no one dressing was superior in all the tests
and there were no significant differences between the
dressings, but felt that Allevyn† was the best all-round
‘pressure-relieving’ dressing. However, in saying that, the
authors inferred that the ability of a dressing to retain
thickness and shape was a pressure-relieving character-
istic but did not substantiate this in any way. They felt
that the ability of the Allevyn† and Biatain† to retain
their thickness in wet conditions with 10% lower strain
when wet than when dry provided possible evidence of
greater cushioning when wet. However, as an in vitro
study, it is difficult to extrapolate findings to the effect
foams have on the wound during gait. An outline of
statistical analysis was not provided; however, it was
mentioned that none of the results were significant.
The second study by Chockalingham et al. (36)
investigated kinematic changes associated with the appli-
cation of the same array of foam dressings described in
the previous study to the feet of a normal subject sample.
A strain gauge force plate system was utilised to test the
same dressings as above on six healthy subjects with
‘normal’ gait patterns. The 5 cm 5 cm dressings were
applied to cover the plantar surface of the metatarsal
heads. Subjects walked over the force plate, and datawere
assessed for anterior posterior, medial lateral and verti-
cal components of the ground reaction force and their
moments. Findings showed that the ground reaction
forces measured with the Allevyn† were closest to
barefoot in peak push-off, whereas others were noticeably
raised. It was not reported if this finding was significant
or not. Of direct relevance to the current study, they also
found that Allevyn† resulted in a small reduction in the
vertical component of the ground reaction force in five
out of six subjects. Again, it was felt that Allevyn†, with
its increased shock absorption capability and braking,
could be considered to provide better pressure-relieving
properties than other dressings (36). As with the earlier
study, no details of statistical analysis were provided. It
was not reported if any of the findings were significant.
They concluded that further study was necessary. Whilst
kinematic measures are important, this is not necessarily
as clinically applicable as measuring direct plantar
pressures over specific areas of the foot.
The third study of note also published by Chockaling-
ham et al. (37) used a force plate to investigate the effects
of pressure on foam dressings. In this study the same
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Tielle†)o f5c m  5 cm were applied to the plantar heel
of only four ‘normal’ subjects and tested using the same
strain gauge force plate as the previously described study.
A similar outcome to previous studies was reported, with
suggestions that Allevyn† performed closest to barefoot.
However, in this study, Lyofoam† showed a decrease in
reaction force, but it was commented that whilst this
shows shock absorbing properties, this asymmetry of
loading is an important indicator of gait dysfunction (37).
It was not reported if any of these findings were
significant. This study investigated the effect of the
foam on the heel only which is not a common site for
plantar ulceration as a result of dynamic biomechanics
(5, 38). Rather, this occurs more commonly as a result of
constant static pressures when a patient spends excessive
time bed-bound or in a supine position with pressure
localised to the heel, thereby restricting local blood flow.
Thus, it appears that significant gaps still exist in our
knowledge of the interaction of foam dressings and
dynamic plantar pressures, particularly in the forefoot.
It is important that this gap is addressed to better inform
dressing choices in the management of plantar ulcera-
tions. Thus, the aim of this study was to measure changes
in plantar pressure variables as a direct result of the
application of foam dressings. To avoid ethical concerns
regarding the application of plantar dressings that may or
may not increase pressures on a diabetic wound, it was
decided that a pilot study on a healthy population should
precede any further research on high-risk participants.
Materials and methods
In summary, studies to date have not addressed the
clinical application of foam dressings either through in
vivo methods, addressing prevalent site of ulceration from
dynamic causes or utilised clinically applicable measures.
Therefore, to try and improve this situation, we elected to
undertake a study comparing peak plantar pressures
(Ppp) and pressure time integrals (Pti) for three foam
dressings with a control in healthy subjects during
dynamic gait. Ptis recognise the duration over which
the plantar pressures are applied to a particular region.
A double-blinded within-subject, experimental design
was used on a sample of convenience. Ethics approval
was obtained from the University of South Australia,
Human Research Ethics Committee. Thirty-one subjects
were recruited and consent obtained. Subjects were
excluded if they had neuropathy, a poor vascular status,
a current or previous ulceration, poor skin integrity,
oedema, unsuitable footwear, an allergy to dressings or
adhesive tapes or a medical history suggesting the
presence of any risk associated with participating in the
study. If subjects had callus present, this was debrided to
reduce the likelihood of recording falsely high pressures
and to reflect current wound management practice.
The F-Scan v6.3 (Tekscan Inc., Boston, MA, USA) in-
shoe computerised pressure measurement device was
used to collect data. Subjects were allowed to wear their
own appropriate footwear without alteration to hosiery,
insoles or similar, provided the conditions were kept
consistent between sampling. A sampling rate of 50 Hz
was used, the minimum recommended for walking
measurements (39). Before calibration and measurement,
a5  10 min conditioning period was undertaken to meet
the 2 min requirements for ‘bedding in’ as outlined by
Pitei et al. (32) and the 5 10 min period suggested by
Mueller and Strube (40) to decrease sensor variation and
enable the subjects to familiarise themselves with the in-
shoe sensors. F-scan calibration was undertaken using the
method outlined in the F-scan v.6.3x user manual (41).
Subsequent to calibration, measures were taken barefoot
to allow the subject to get used to the recording
procedure. Following this acclimatisation, measurements
were taken with each of the three separate foam dressings
(Allevyn, Lyofoam and Mepilex) chosen to represent
those used regularly in local hospital clinics and a
standard plain dressing (Melolin) to act as the control;
all were applied directly to the foot. Melolin was selected
to act as the control due to its low profile and ease of
application whilst maintaining the need for a ‘sham’
Skin indentation due to 
foam dressing 
Fig. 1. Wound that had been dressed with foam dressing (note the indentation).
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prised part of the acclimatisation period, were not
randomised and obviously not able to be blinded to
participants and consequently were not included in
statistical analysis. Dressings were applied in a random
order by a third party with blinding applied to both the
subject and examiner. Dressings were of standard size 5
cm 5 cm. Any dressing larger than this was cut to the
appropriate size. Dressings were applied to the first
metatarsophalangeal joint (MPJ) of the right or left
foot of every subject and fixed in place using hypafix tape
dressing, chosen due to its frequent use in the clinical
setting. The first MPJ was chosen as it is a common place
for ulceration (5, 38, 42), is an easy site for dressing
application and corresponds with a specific area of
masking. Subjects walked along a 10-m long walkway
and readings were recorded. All measurements were
undertaken in a single session as it provides greater
reliability if a force platform is not used for calibration
(40). Subjects were allowed to walk at a self-selected pace.
The process of ‘masking’ involves the separation of the
foot into discrete areas to allow for pressure comparisons
within each of the areas, rather than across the foot as a
whole. This provides more meaningful data by enabling
more specific comparisons of these particular areas and
also enables investigators to examine any transferring of
the pressures. There appears to be no consistently
recognised method of masking the foot. The most recent
version of the F-scan (v.6.3x) Versatek
TM software has a
semi-automatic masking method whereby masking tem-
plates can be automatically applied to the foot and then
manually altered to match the required profile, if the
software unsuccessfully or inaccurately identifies the
required landmarks. This software automatically divides
the foot into the following regions: the medial heel,
lateral heel, midfoot area, metatarsal 1, metatarsal 2,
metatarsal 3, metatarsal 4 and metatarsal 5, toe 1, toe 2,
toe 3 and toes 4/5 (Fig. 2).
When comparing Ppp and Pti data, the average from
an aggregate of at least three steps is commonly used to
avoid the variation that may exist between individual
steps. This process also allows the elimination of the first
and last steps to reduce the effects of acceleration and
deceleration. Data comparing each of the conditions were
compared with control to analyse for change. Initially,
descriptive statistics were investigated, determining the
means and standard deviations for the quantity of change
at each of the masked sites under each condition, to
provide an understanding of the mean and distribution of
the data. Data analysis was undertaken using ANOVA
followed by individual t-tests with post-hoc Bonferroni
correction to investigate for significant change.
Results
Twelve males and 19 females mean [SD] age 36.6 [10.4]
years participated in the study. Table 1 summarises the
mean (standard deviation) for Ppp changes across the
total foot, and each of the mask regions, for each foam
dressing. Substantial variations in individual pressure
changes occurred across the foot. Statistical analysis was
undertaken to specifically assess for significance or lack
thereof. ANOVA’s were calculated for each of the condi-
tions to assess for any change (Table 2) but showed no
significance across any of the conditions within any of the
regions. Two tailed t-tests were undertaken comparing the
means across the whole foot and each of the 12 regions to
assess for individual change with the conditions (Tables
3 5). The only significant change was identified when
Mepilex was compared to control, with a p-value of 0.046
for the Ppp and a p-value of 0.034 (Table 5) for the Ptis.
However, this is no longer the case when a Bonferroni
correction is applied to account for the multiple compar-
isons (a value of 0.016).
Discussion
The Ppp changes recorded at each of the mask regions
were quite varied with no uniform response. Ptis, whilst
slightly less variable than Ppp, were still inconsistent. No
statistical significance was found between any of the
conditions on the foot overall or any of the regions. This
does not seem to fit with our current understanding of
pressure principles. Given that previous authors have
successfully measured increased pressure changes to the
plantar surface of the foot resulting from the presence of
Fig. 2. Sample image of recorded stance with masking template applied.
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(43). At a statistical level, the lack of significance can be
explained by the large variation in the means and
standard deviations of the change between each of the
conditions. There may be a couple of reasons for these
findings. It may be that there are simply no significant
differences between the foam dressings and a control
dressing, or between the foam dressings themselves. This
would fit with the earlier reported papers where there was
a lack of significance (35 37). This may also provide
useful information to practitioners involved in wound
management as it means that dressing choice may not
detrimentally affect plantar pressures and subsequent
wound healing. However, one must keep in mind that the
converse of this is that there is no evidence that the
dressing is able to significantly decrease the plantar
pressures on the foot by a simple method of ‘cushioning’
the wound. An alternative explanation is that despite
recruiting subject numbers to sufficiently meet the crude
power analysis, the lack of findings may be due to a type
II error brought about due to methodological issues or
limitations. In the past, issues have been raised with the
validity and reliability of the F-scan device (40, 44 46),
with the calibration process and possible creep of the
insoles (46, 47). Additionally, there have been issues
raised with the use of the F-scan on varying surface
hardness (47). Variability may have been introduced by
allowing subjects to wear their own footwear, rather than
standardising footwear and insole hardness.
Consequently, we must acknowledge that we have
inadvertently introduced confounders by our choice to
use this tool and the protocol employed. Also, using this
tool, we are only able to measure the dressing shoe
interface at the location where the foam was applied and
is therefore only a pseudo measure of the foot-dressing
interface. This may not represent the true forces acting on
Table 2. ANOVA of plantar regions.
ANOVA
P-value peak
plantar pressure
P-value Pressure 
time integral
Hallux 0.965277 0.984663
Second digit 0.94332 0.765596
Third digit 0.91441 0.973133
Fourth/fifth digit 0.708602 0.956613
First MPJ 0.97369 0.998888
Second MPJ 0.987374 0.996001
Third MPJ 0.995552 0.965631
Fourth MPJ 0.893907 0.945277
Fifth MPJ 0.980164 0.901253
Arch 0.910872 0.997631
Medial heel 0.972203 0.963101
Lateral heel 0.73985 0.869682
Table 3. T-test comparison Allevyn.
Allevyn vs. control Ppp P-ti
Overall 0.506 0.957
Hallux 0.703 0.991
Two digit 0.787 0.377
Three digit 0.873 0.228
Four/five digit 0.711 0.926
First MPJ 0.787 0.640
Second MPJ 0.626 0.333
Third MPJ 0.687 0.464
Fourth MPJ 0.239 0.366
Fifth MPJ 0.294 0.074
Arch 0.916 0.625
Medial heel 0.500 0.474
Lateral heel 0.244 0.411
Table 4. T-test comparison Lyofoam.
Lyofoam vs. control Ppp P-ti
Overall 0.169 0.062
Hallux 0.566 0.524
Two digit 0.401 0.109
Three digit 0.250 0.232
Four/five digit 0.429 0.473
First MPJ 0.939 0.915
Second MPJ 0.322 0.919
Third MPJ 0.312 0.441
Fourth MPJ 0.400 0.716
Fifth MPJ 0.822 0.4
Arch 0.386 0.651
Medial heel 0.117 0.063
Lateral eel 0.386 0.61
Table 1. Peak plantar pressures*mean changes.
Control vs.
Allevyn
Control vs.
Lyofoam
Control vs.
Mepilex
Overall 0.18 (5.21) 0.38 (5.25) 0.61 (5.84)
Hallux  0.43 (6.16)  1.02 (9.80)  1.79 (8.88)
Second digit 0.28 (5.70)  0.89 (5.84)  0.49 (5.38)
Third digit  0.13 (4.43)  1.07 (5.09)  0.18 (4.32)
Fourth/fifth
digit
 0.31 (4.59)  0.61 (4.21)  0.83 (5.79)
First MPJ 0.38 (7.81)  0.08 (5.59)  1.06 (8.11)
Second MPJ  0.32 (3.64)  0.60 (3.32)  1.34 (8.57)
Third MPJ  0.32 (4.43)  0.80 (4.32)  0.38 (5.20)
Fourth MPJ 0.86 (4.01) 0.83 (5.44)  0.55 (4.62)
Fifth MPJ 0.64 (3.33) 0.15 (3.77) 0.03 (5.45)
Arch 0.09 (4.72) 0.97 (6.11)  0.29 (3.15)
Medial Heel  0.35 (2.86)  0.86 (2.96)  0.92 (3.82)
Lateral Heel 1.76 (8.27)  0.53 (3.35) 0.52 (4.10)
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may have led to false readings at this interface.
However, the single biggest issue is that, similarly with
those studies reviewed above, this study was undertaken
on a normal healthy population. It is quite possible that a
person with normal sensation may feel slight variations in
pressure caused by the dressing on the foot and compen-
sate for this at a subconscious level during stance and
gait. It has been shown that a person with inadequate
sensation shows less variation in his or her centre of
pressure during gait, than a sensate person (48). This is
believed to occur due to the lack of nociceptive feedback.
In a sensate person, there is subconscious variation to
prevent an accumulative increase in pressure in a
particular area over numerous steps. Therefore, the result
of applying a dressing to an insensate foot may have
vastly different outcomes due to the lack of feedback that
has likely occurred in this sample.
Conclusion
In this sample of young healthy adults, application of
different foam dressings did not significantly alter Ppp or
Ptis. Superficially, we could conclude from this study and
those reviewed that the effect of wound dressings,
specifically foam dressings, on the plantar surface may
not significantly impact the decision making an appro-
priate dressing choice. However, before final conclusions
can be made, this article highlights, more than anything,
the need for a robust repeated measures observational
trial on a pathological population. Furthermore, future
studies need to consider the availability of reliable best
practice tools for plantar pressure measurement to ensure
sufficient sensitivity required.
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